Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.9 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.023 | 0.9 |